Pelvic DiseasesNCT02337777
The Study of Functional Magnetic Resonance Imaging in Abdominal and Pelvic Diseases
An observational study of Pelvic Diseases and Abdominal Diseases, run by Tongji Hospital at 1 site in China.
Trial summary
The purpose of this study is to study the diagnostic efficiency of functional magnetic resonance imaging in Abdominal and Pelvic Diseases. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Pelvic Diseases, Abdominal Diseases
- How many people
- 1,000 participants
- Where
- 1 siteChina
- Study dates
- Jul 2014to Dec 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: All patients with abdominal or pelvic diseases who provide informed consent Healthy Volunteers
Who may be able to join
- All patients with abdominal or pelvic diseases who provide informed consent
- Healthy Volunteers
Who cannot join
- claustrophobic
- pregnancy
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
Tongji Hospital affiliated to Tongji Medical college of Huazhong Universitity of Science and Technology
Wuhan, Hubei, 430030
Hu Daoyu, PhD, +86 13986297890, cjr.hudaoyu@vip.163.com
Chen Xiao, MD, +86 13476841612, chx@hust.edu.cn
About this study
The purpose of this study is to study the diagnostic efficiency of functional magnetic resonance imaging in Abdominal and Pelvic Diseases.
- Conditions
- Pelvic Diseases, Abdominal Diseases
- Keywords
- Magnetic Resonance Imaging, Magnetic Resonance Angiography, Diffusion Tensor Imaging, IDEAL, T2* mapping, Magnetic ResonanceCine, BOLD, phase contrast, diffusion-weighted imaging, Functional Magnetic Resonance Imaging
What is being measured
The primary outcome is the main question the study is designed to answer.
all cause mortality
Measured: 10years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2015 (estimated)
- Study startJul 2014
- Primary completionDec 2019 (estimated)
- Study completionDec 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Pelvic DiseasesStudies of the same condition, open and under way.
- More trials run by Tongji HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tongji Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hu Daoyu, Tongji Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02337777
- Sponsor's protocol ID
- S097
- Status last verified
- Jan 2018
- First submitted
- 9 Jan 2015
- Last updated
- 17 Jan 2018
- Results posted
- No
Publications
Tang H, Wang Z, Wang L, Hu X, Wang Q, Li Z, Li J, Meng X, Wang Y, Hu D. Depiction of transplant renal vascular anatomy and complications: unenhanced MR angiography by using spatial labeling with multiple inversion pulses. Radiology. 2014 Jun;271(3):879-87. doi: 10.1148/radiol.14131800. Epub 2014 Mar 3.
PubMed 24592960Wang YC, Hu DY, Hu XM, Shen YQ, Meng XY, Tang H, Li Z. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study. Chin Med J (Engl). 2016 Mar 20;129(6):665-71. doi: 10.4103/0366-6999.177995.
PubMed 26960369Wang Y, Li Z, Meng X, Hu X, Shen Y, Morelli J, Lin H, Zhang Z, Hu D. Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer: Image Quality and Clinical Value of Reduced Field-of-view Versus Conventional Single-shot Echo-planar Imaging DWI. Medicine (Baltimore). 2016 Mar;95(10):e2951. doi: 10.1097/MD.0000000000002951.
PubMed 26962794
Study at a glance
From the registry record, last updated by the sponsor on 17 Jan 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Study of Functional Magnetic Resonance Imaging in Abdominal and Pelvic Diseases
- ClinicalTrials.gov ID
- NCT02337777
- Acronym / sponsor ID
- S097
- Conditions
- Pelvic Diseases, Abdominal Diseases
- Keywords
- Magnetic Resonance Imaging, Magnetic Resonance Angiography, Diffusion Tensor Imaging, IDEAL, T2* mapping, Magnetic ResonanceCine, BOLD, phase contrast
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- Tongji HospitalUniversity, hospital or other
- Study start
- Jul 2014
- Primary completion
- Dec 2019 (estimated)
- Study completion
- Dec 2019 (estimated)
- First posted
- 14 Jan 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to study the diagnostic efficiency of functional magnetic resonance imaging in Abdominal and Pelvic Diseases.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- All patients with abdominal or pelvic diseases who provide informed consent Healthy Volunteers
Key inclusion criteria (2 listed)
- All patients with abdominal or pelvic diseases who provide informed consent
- Healthy Volunteers
Key exclusion criteria (2 listed)
- claustrophobic
- pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
all cause mortality
Time frame: 10years
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jan 2018.
- Results publication: PubMed 24592960Tang H, Wang Z, Wang L, Hu X, Wang Q, Li Z, Li J, Meng X, Wang Y, Hu D. Depiction of transplant renal vascular anatomy and complications: unenhanced MR angiography by using spatial labeling with multiple inversion pulses. Radiology. 2014 Jun;271(3):879-87. doi: 10.1148/radiol.14131800. Epub 2014 Mar 3.
- Results publication: PubMed 26960369Wang YC, Hu DY, Hu XM, Shen YQ, Meng XY, Tang H, Li Z. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study. Chin Med J (Engl). 2016 Mar 20;129(6):665-71. doi: 10.4103/0366-6999.177995.
- Results publication: PubMed 26962794Wang Y, Li Z, Meng X, Hu X, Shen Y, Morelli J, Lin H, Zhang Z, Hu D. Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer: Image Quality and Clinical Value of Reduced Field-of-view Versus Conventional Single-shot Echo-planar Imaging DWI. Medicine (Baltimore). 2016 Mar;95(10):e2951. doi: 10.1097/MD.0000000000002951.
Related trials for Pelvic Diseases
Recruiting
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Prostate Cancer, Urinary Incontinence
Active, not recruitingPhase 1
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)
Prostate Cancer, Prostate Adenocarcinoma
Recruiting
Effects of Pelvic Floor Muscle Training and a Modified Lumbopelvic Belt on Pain, Kinesiophobia, and Functional Status in Pregnant Women With Symphysis Pubis Pain
Symphysis Pubis Dysfunction, Pregnancy
Active, not recruitingPhase 2
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
Prostate Cancer
RecruitingPhase 1
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Urinary Bladder Neoplasms, Neoplasm Metastasis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pelvic Diseases and Abdominal Diseases, run by Tongji Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 17 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Hu Daoyu, PhD (+86 13986297890, cjr.hudaoyu@vip.163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
all cause mortality (time frame: 10years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02337777, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2018.